Connect with us

Health & Fitness

IDSA Updates COVID Guidelines for Antibodies, Antivirals, Others

Infectious disease experts critically review evidence for use of bamlanivimab, address new data on remdesivir and tocilizumab, and comment on new findings for the Oxford University COVID-19 vaccine. Medscape Medical News

Published

on

IDSA Updates COVID Guidelines for Antibodies, Antivirals, Others